Viewing Study NCT02342067


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-01-24 @ 7:49 AM
Study NCT ID: NCT02342067
Status: COMPLETED
Last Update Posted: 2015-05-12
First Post: 2015-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination
Sponsor: Tobira Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 652-1-122
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators